Significance of data analysis in the quality control of prenatal screening for Down syndrome

被引:7
|
作者
Li, Yahong [1 ]
Zhang, Xiaojuan [1 ]
Hong, Dongyang [1 ]
Guan, Xianwei [1 ]
Lv, Shaolei [2 ]
Sun, Yun [1 ]
Jiang, Tao [1 ]
机构
[1] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Ctr Prenatal Diag, Affiliated Obstet & Gynecol Hosp, 123 Tianfei Rd, Nanjing 210004, Jiangsu, Peoples R China
[2] Zhejiang Biosan Biochem Technol Co Ltd, Hangzhou 310000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
quality control; prenatal screening; Down syndrome;
D O I
10.3892/br.2018.1078
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dual detection of alpha-fetoprotein (AFP) and free beta-human chorionic gonadotropin (beta-HCG) is a common screening method for Down syndrome in the second trimester and its efficacy is assessed by false-positive rate (FPR). The present study aimed to investigate the effects of the bias in median multiple of the median (mMoM) values of AFP and free beta-HCG on FPR. The bias in mMoM values of AFP and free beta-HCG and the bias in mMoM values under different gestational ages and weight groups were analyzed. Median equations were adjusted, and medians in LifeCycle software were replaced by local medians. Following two adjustments of the median equations, all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. In conclusion, abnormal bias in mMoM values may prompt aberrant application of median equations, and regular monitoring of these indicators may be important for quality control in prenatal screening.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [31] The Status of Quality Control Investigation and Analysis for Maternal Serum Marker of Prenatal Screening Laboratories in China
    He, Falin
    Wang, Wei
    Zhong, Kun
    Yuan, Shuai
    Wang, Zhiguo
    CLINICAL LABORATORY, 2017, 63 (01) : 183 - 188
  • [32] An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test
    Huttly, Wayne J.
    Wald, Nicholas J.
    PRENATAL DIAGNOSIS, 2011, 31 (13) : 1317 - 1317
  • [33] Verification of foetal Down syndrome biomarker proteins in maternal plasma and applications in prenatal screening for Down syndrome
    Weiguo Sui
    Qing Gan
    Wei Wei Gong
    Xiaolian Wei
    Minglin Ou
    Donge Tang
    Huanyun Jing
    Hua Lin
    Yue Zhang
    Yong Dai
    Translational Medicine Communications, 3 (1)
  • [34] Prenatal screening for Down syndrome in Australia: Costs and benefits of current and novel screening strategies
    O'Leary, Peter
    Maxwell, Susannah
    Murch, Ashleigh
    Hendrie, Delia
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2013, 53 (05) : 425 - 433
  • [35] Prenatal screening for Down's syndrome: some psychosocial implications of a 'screening for all' policy
    Bryant, LD
    Green, JM
    Hewison, J
    PUBLIC HEALTH, 2001, 115 (05) : 356 - 358
  • [36] The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome
    Buczynska, Angelika
    Sidorkiewicz, Iwona
    Lawicki, Slawomir
    Kretowski, Adam
    Zbucka-Kretowska, Monika
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 8
  • [37] Prenatal Testing for Down Syndrome: Comparison of Screening Practices in the UK and USA
    Tapon, Dagmar
    JOURNAL OF GENETIC COUNSELING, 2010, 19 (02) : 112 - 130
  • [38] Prenatal screening for Down's syndrome with maternal markers: Tunisian experience
    Ferchichi, S.
    Chahed, H.
    Jaidane, Z.
    Chaabouni, Y.
    Saafi, N.
    Limem, H. B.
    Sakouhi, M.
    Bernard, M.
    Khairi, H.
    Laradi, S.
    Miled, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2010, 25 (04): : 205 - 211
  • [39] Quality control of ultrasonography markers for Down's syndrome screening: a retrospective study by the laboratory
    Badal, Blanca
    Ballesteros, Antonieta
    Crespo, Miriam
    Morell-Garcia, Daniel
    Miquel Bauca, Josep
    Pastor, Maria
    Ruiz de Gopegui, Rosa
    Martin, Inmaculada
    DIAGNOSIS, 2021,
  • [40] Ethnic differences in considerations whether or not to participate in prenatal screening for Down syndrome
    Fransen, Mirjam P.
    Wildschut, Hajo I. J.
    Vogel, Ineke
    Mackenbach, Johan P.
    Steegers, Eric A. P.
    Essink-Bot, Marie-Louise
    PRENATAL DIAGNOSIS, 2009, 29 (13) : 1262 - 1269